BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20560933)

  • 1. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome: an alternative approach.
    Baker SG
    Biometrics; 2011 Mar; 67(1):319-23; discussion 323-5. PubMed ID: 20560933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
    Cheng J
    Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Likelihood-based inference for bounds of causal parameters.
    Lee W; Sjölander A; Larsson A; Pawitan Y
    Stat Med; 2018 Dec; 37(30):4695-4706. PubMed ID: 30155912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
    Chen H; Geng Z; Zhou XH
    Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Cox analysis of a randomized survival study yield a causal treatment effect?
    Aalen OO; Cook RJ; Røysland K
    Lifetime Data Anal; 2015 Oct; 21(4):579-93. PubMed ID: 26100005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 8. Causal models for randomized trials with two active treatments and continuous compliance.
    Ma Y; Roy J; Marcus B
    Stat Med; 2011 Aug; 30(19):2349-62. PubMed ID: 21751229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint modeling compliance and outcome for causal analysis in longitudinal studies.
    Gao X; Brown GK; Elliott MR
    Stat Med; 2014 Sep; 33(20):3453-65. PubMed ID: 23576159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
    Schuler MS; Rose S
    Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating prognostic factors into causal estimators: a comparison of methods for randomised controlled trials with a time-to-event outcome.
    Hampson LV; Metcalfe C
    Stat Med; 2012 Nov; 31(26):3073-88. PubMed ID: 22714785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient design and inference for multistage randomized trials of individualized treatment policies.
    Dawson R; Lavori PW
    Biostatistics; 2012 Jan; 13(1):142-52. PubMed ID: 21765180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal structural mixed models for the analysis of surgical trials with noncompliance.
    Sitlani CM; Heagerty PJ; Blood EA; Tosteson TD
    Stat Med; 2012 Jul; 31(16):1738-60. PubMed ID: 22344923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted maximum likelihood estimation of the parameter of a marginal structural model.
    Rosenblum M; van der Laan MJ
    Int J Biostat; 2010; 6(2):Article 19. PubMed ID: 21731532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials.
    Mallinckrodt CH; Lin Q; Molenberghs M
    Pharm Stat; 2013; 12(1):1-6. PubMed ID: 23193075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal inference in paired two-arm experimental studies under noncompliance with application to prognosis of myocardial infarction.
    Bartolucci F; Farcomeni A
    Stat Med; 2013 Nov; 32(25):4348-66. PubMed ID: 23754710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating treatment effect in a proportional hazards model in randomized clinical trials with all-or-nothing compliance.
    Li S; Gray RJ
    Biometrics; 2016 Sep; 72(3):742-50. PubMed ID: 26799700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical likelihood inference in randomized clinical trials.
    Zhang B
    Stat Methods Med Res; 2018 Dec; 27(12):3770-3784. PubMed ID: 28679341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.